These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 15516472)

  • 1. Risk factors of treatment failure in community acquired pneumonia: implications for disease outcome.
    Menéndez R; Torres A; Zalacaín R; Aspa J; Martín Villasclaras JJ; Borderías L; Benítez Moya JM; Ruiz-Manzano J; Rodríguez de Castro F; Blanquer J; Pérez D; Puzo C; Sánchez Gascón F; Gallardo J; Alvarez C; Molinos L;
    Thorax; 2004 Nov; 59(11):960-5. PubMed ID: 15516472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early and late treatment failure in community-acquired pneumonia.
    Garcia-Vidal C; Carratalà J
    Semin Respir Crit Care Med; 2009 Apr; 30(2):154-60. PubMed ID: 19296415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Causes and factors associated with early failure in hospitalized patients with community-acquired pneumonia.
    Rosón B; Carratalà J; Fernández-Sabé N; Tubau F; Manresa F; Gudiol F
    Arch Intern Med; 2004 Mar; 164(5):502-8. PubMed ID: 15006826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Community-acquired pneumonia in patients with and without chronic obstructive pulmonary disease.
    Molinos L; Clemente MG; Miranda B; Alvarez C; del Busto B; Cocina BR; Alvarez F; Gorostidi J; Orejas C;
    J Infect; 2009 Jun; 58(6):417-24. PubMed ID: 19329187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment failure rates and health care utilization and costs among patients with community-acquired pneumonia treated with levofloxacin or macrolides in an outpatient setting: a retrospective claims database analysis.
    Ye X; Sikirica V; Schein JR; Grant R; Zarotsky V; Doshi D; Benson CJ; Riedel AA
    Clin Ther; 2008 Feb; 30(2):358-71. PubMed ID: 18343274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health care-associated pneumonia and community-acquired pneumonia: a single-center experience.
    Micek ST; Kollef KE; Reichley RM; Roubinian N; Kollef MH
    Antimicrob Agents Chemother; 2007 Oct; 51(10):3568-73. PubMed ID: 17682100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors and outcome of community-acquired pneumonia due to Gram-negative bacilli.
    Falguera M; Carratalà J; Ruiz-Gonzalez A; Garcia-Vidal C; Gazquez I; Dorca J; Gudiol F; Porcel JM
    Respirology; 2009 Jan; 14(1):105-11. PubMed ID: 18699803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [An addition to the clinical algorithm for treatment of patients with community-acquired pneumonia in Bosnia-Herzegovina: a multicenter prospective study in Sarajevo].
    Mehić B; Dizdarević Z; Zutić H
    Med Arh; 1999; 53(3 Suppl 3):79-81. PubMed ID: 10870635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Empiric treatment in hospitalized community-acquired pneumonia. Impact on mortality, length of stay and re-admission.
    Reyes Calzada S; Martínez Tomas R; Cremades Romero MJ; Martínez Moragón E; Soler Cataluña JJ; Menéndez Villanueva R
    Respir Med; 2007 Sep; 101(9):1909-15. PubMed ID: 17628462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison between pathogen directed antibiotic treatment and empirical broad spectrum antibiotic treatment in patients with community acquired pneumonia: a prospective randomised study.
    van der Eerden MM; Vlaspolder F; de Graaff CS; Groot T; Bronsveld W; Jansen HM; Boersma WG
    Thorax; 2005 Aug; 60(8):672-8. PubMed ID: 16061709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple-drug-resistant bacteria in patients with severe acute exacerbation of chronic obstructive pulmonary disease: Prevalence, risk factors, and outcome.
    Nseir S; Di Pompeo C; Cavestri B; Jozefowicz E; Nyunga M; Soubrier S; Roussel-Delvallez M; Saulnier F; Mathieu D; Durocher A
    Crit Care Med; 2006 Dec; 34(12):2959-66. PubMed ID: 17012911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Causes and risk factors for rehospitalization of patients hospitalized with community-acquired pneumonia.
    Jasti H; Mortensen EM; Obrosky DS; Kapoor WN; Fine MJ
    Clin Infect Dis; 2008 Feb; 46(4):550-6. PubMed ID: 18194099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns of health care resource utilization after macrolide treatment failure: results from a large, population-based cohort with acute sinusitis, acute bronchitis, and community-acquired pneumonia.
    Wu JH; Howard DH; McGowan JE; Frau LM; Dai WS
    Clin Ther; 2004 Dec; 26(12):2153-62. PubMed ID: 15823779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors for early clinical failure in patients with severe community-acquired pneumonia.
    Hoogewerf M; Oosterheert JJ; Hak E; Hoepelman IM; Bonten MJ
    Clin Microbiol Infect; 2006 Nov; 12(11):1097-104. PubMed ID: 17002609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reaching stability in community-acquired pneumonia: the effects of the severity of disease, treatment, and the characteristics of patients.
    Menéndez R; Torres A; Rodríguez de Castro F; Zalacaín R; Aspa J; Martín Villasclaras JJ; Borderías L; Benítez Moya JM; Ruiz-Manzano J; Blanquer J; Pérez D; Puzo C; Sánchez-Gascón F; Gallardo J; Alvarez CJ; Molinos L;
    Clin Infect Dis; 2004 Dec; 39(12):1783-90. PubMed ID: 15578400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe community-acquired pneumonia: an Australian perspective.
    Wilson PA; Ferguson J
    Intern Med J; 2005 Dec; 35(12):699-705. PubMed ID: 16313544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guideline-concordant therapy and reduced mortality and length of stay in adults with community-acquired pneumonia: playing by the rules.
    McCabe C; Kirchner C; Zhang H; Daley J; Fisman DN
    Arch Intern Med; 2009 Sep; 169(16):1525-31. PubMed ID: 19752411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of community-acquired pneumonia in patients with chronic obstructive pulmonary disease.
    Pifarre R; Falguera M; Vicente-de-Vera C; Nogues A
    Respir Med; 2007 Oct; 101(10):2139-44. PubMed ID: 17629470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving outcomes in elderly patients with community-acquired pneumonia by adhering to national guidelines: Community-Acquired Pneumonia Organization International cohort study results.
    Arnold FW; LaJoie AS; Brock GN; Peyrani P; Rello J; Menéndez R; Lopardo G; Torres A; Rossi P; Ramirez JA;
    Arch Intern Med; 2009 Sep; 169(16):1515-24. PubMed ID: 19752410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiotic prescription for community-acquired pneumonia in the intensive care unit: impact of adherence to Infectious Diseases Society of America guidelines on survival.
    Bodí M; Rodríguez A; Solé-Violán J; Gilavert MC; Garnacho J; Blanquer J; Jimenez J; de la Torre MV; Sirvent JM; Almirall J; Doblas A; Badía JR; García F; Mendia A; Jordá R; Bobillo F; Vallés J; Broch MJ; Carrasco N; Herranz MA; Rello J;
    Clin Infect Dis; 2005 Dec; 41(12):1709-16. PubMed ID: 16288392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.